In-Person Breakfast Event at the AAD – Exploring the Innovation and Research on Alopecia Areata

Innovaderm was in San Diego for the 2024 edition of the AAD annual meeting and hosted its 5^th Breakfast Event: Exploring the Innovation and Research on Alopecia Areata (AA).

Listen to our world-renowned AA key opinion leaders' presentations to learn about the disease and the latest research findings:

Dr. Brett King - Clinical Evaluations and Current Treatments for AA
Dr. Natasha Mesinkovska - Experimental and Future Treatments of AA

Interested in attending our next event?

Newsletter

Join our science community with Press Forward, our quarterly newsletter. Get the latest in dermatology clinical research. Subscribe now!

Newsletter subscription resources

*By subscribing to our newsletter, you acknowledge and agree to the terms of our privacy policy.

<img src="https://innovaderm.com/wp-content/uploads/2019/04/

Blog Article

Essential Requirements for Adaptive Designs in Clinical Trials

Adaptive design in clinical trials is a dynamic and innovative approach, but it requires certain key elements to ensure its successful implementation. Efficiency and Integrity The purpose of an adaptive trial design is to increase efficiency without compromising the integrity and validity of the results. For this to be accomplished, extensive and adequately maintained clinical […]

Blog Article

The Potential of Adaptive Design in Clinical Trials

Did you know? Adaptive design offers numerous benefits that streamline the drug-development process and bring life-changing medications to patients more rapidly. Adaptive Study Design Help With: Reducing the costs of drug development Contributing to reducing the length of the trial Reducing the time to bring a drug to the market Allowing patients to access to […]

In-Person Breakfast Event at the AAD – Exploring the Innovation and Research on Alopecia Areata

Newsletter subscription resources

Top 10 Rheumatology Clinical Trial Topics at the Upcoming Edition of ACR 2024

Essential Requirements for Adaptive Designs in Clinical Trials

The Potential of Adaptive Design in Clinical Trials